Atlas Trials

A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma

Clinical trial NCT06478264 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06478264
Sponsor
Zhangzhou Municipal Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Small Cell Carcinoma
Start date
2024-07-13
Primary completion
2026-07-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.